REEBX
Price
$50.75
Change
+$2.42 (+5.01%)
Updated
Apr 9 closing price
Net Assets
110.84B
SCIIX
Price
$6.59
Change
+$0.45 (+7.33%)
Updated
Apr 9 closing price
Net Assets
299.02M
Ad is loading...

REEBX vs SCIIX

Header iconREEBX vs SCIIX Comparison
Open Charts REEBX vs SCIIXBanner chart's image
American Funds Europacific Growth R2E
Price$50.75
Change+$2.42 (+5.01%)
VolumeN/A
Net Assets110.84B
Virtus SGA International Growth A
Price$6.59
Change+$0.45 (+7.33%)
VolumeN/A
Net Assets299.02M
REEBX vs SCIIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
REEBX vs. SCIIX commentary
Apr 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REEBX is a Hold and SCIIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
REEBX has more cash in the bank: 111B vs. SCIIX (299M). REEBX pays higher dividends than SCIIX: REEBX (0.72) vs SCIIX (0.01). REEBX was incepted earlier than SCIIX: REEBX (11 years) vs SCIIX (29 years). SCIIX (1.57) is less costly to investors than REEBX (1.27). REEBX is a more actively managed with annual turnover of: 30.00 vs. SCIIX (10.00). REEBX has a lower initial minimum investment than SCIIX: REEBX (250) vs SCIIX (2500). REEBX annual gain was more profitable for investors over the last year : -15.62 vs. SCIIX (-32.45). REEBX return over 5 years is better than : 11.80 vs. SCIIX (-32.52).
REEBXSCIIXREEBX / SCIIX
Total Expense Ratio1.271.3098%
Annual Report Gross Expense Ratio1.271.5781%
Fund Existence11 years29 years-
Gain YTD-8.379-7.946105%
Front LoadN/A6%-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets111B299M37,124%
Annual Yield % from dividends0.720.018,645%
Returns for 1 year-15.62-32.4548%
Returns for 3 years-10.53-35.2330%
Returns for 5 years11.80-32.52-36%
Returns for 10 years-2.93-41.717%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TNVRX14.06N/A
N/A
1290 GAMCO Small/Mid Cap Value R
LHCVX16.79N/A
N/A
Lord Abbett Health Care R6
MMZOX15.18N/A
N/A
MassMutual Equity Opports Y
FDECX17.59N/A
N/A
Fidelity Advisor Capital Development C
TQMIX14.68N/A
N/A
AMG TimesSquare Mid Cap Growth I